Micro-computed tomography (µCT) provides extremely high-resolution images of samples and can be employed as a non-destructive inspection tool. Using µCT, we can obtain images comparable with microscopic images. In this work, we have attempted to take high-resolution images of the human lung using µCT. Compared to clinical high-resolution computed tomography (HRCT) images of living body (in-vivo imaging), we can obtain extremely high-resolution images by µCT of ex-vivo tissues (resected lungs) as three-dimensional data. The purpose of this study was to distinguish between areas of normal lung and lung cancer by µCT images in order to study the feasibility of cancer diagnosis using this novel radiological image modality. Ten resected human lungs containing primary cancer were fixed by Heitzman's methods to obtain high-resolution µCT images. After fixation of the lung, images of the specimens were taken by µCT between January 2016 and November 2017. The imaging conditions were tube voltage: 90 kV and tube current: 110 µA. To compare details of images gained by conventional HRCT and µCT, we measured the thickness of the alveolar walls of the normal lung area and the cancer area of which alveoli might be replaced by tumor cells, and compared their appearance by means of histopathological images. All the nodules were diagnosed as adenocarcinoma. The median whole tumor size was 18 mm (9 mm-24 mm). Each specimen was clearly divided into areas of normal alveolar wall and of thickened alveolar wall on µCT 'visually'. Median thickness of alveolar walls of the normal lung was 0.037 mm (0.034 mm-0.048 mm), and that of the cancer area was 0.084 mm (0.074 mm-0.094 mm); there was a statistically significant difference between both thicknesses by Student's t-test (P < 0.01). The area of thickened alveolar walls on µCT corresponded well with the area of microscopically lepidic growth patterns of adenocarcinoma. We found that µCT images could be correctly divided by alveolar walls into normal lung area and lung cancer area. Further detailed investigations with regard to µCT are needed to make comparable histological diagnoses using µCT images with conventional microscopic methods of pathological diagnoses.
INTRODUCTION
Some lung adenocarcinomas exhibit areas of ground glass opacity (GGO) on high-resolution computed tomography (HRCT), reflecting a lepidic growth pattern of tumor cells microscopically. 1 Therefore, lung tumors that display areas of focal GGO on HRCT contain components of histological lepidic tumor growth. 2 Pathological lepidic growth components of those adenocarcinomas show thickened alveolar walls because of tumor growth along with alveolar walls, and the change of the alveoli reflects areas of GGO on HRCT.
Micro-computed tomography (µCT) provides extremely high-resolution images of samples and can be used as a non-destructive inspection tool. It allows us to obtain images comparable with microscopic images. In this study we have attempted to take high-resolution images of the human lung using µCT. Several researchers have reported that alveolar ducts and pulmonary alveoli could be identified on µCT images. [3] [4] [5] [6] However, it was difficult to achieve a direct observation of cancer cells on µCT images even with high-quality images of the lung.
The aim of this study was to detect adenocarcinoma of the lung by µCT. It became possible to distinguish normal lung from adenocarcinomas with lepidic growth pattern on µCT images not only visually but also pathologically. Nevertheless, it was still impossible to make pathological diagnoses based on µCT images alone other than adenocarcinoma with lepidic growth pattern. Based on these facts, this study was pilot study that showed pathological diagnoses of lepidic growth pattern performed only by µCT images. To evaluate how clear those images were, we compared thickness of the alveolar walls between areas of the normal lung and lung adenocarcinoma with the lepidic growth pattern. This study was first report which investigated images of lung cancer using μCT We showed µCT images in which thickened alveolar walls could be observed in lung cancer areas. This finding could be a surrogate for imaging cancer cells in adenocarcinoma specimens.
MATERIALS AND METHODS

Lung samples
Resected lungs containing primary cancer from ten patients were enrolled in this study, which were diagnosed as adenocarcinoma with part-solid or non-solid nodules on preoperative HRCT images in Nagoya University Hospital between January 2016 and November 2017. All information on radiological and pathological variables was collected from the medical records. This study protocol was approved by the institutional review boards (UMIN000015930). Informed consent was obtained before surgery from each patient.
Tissue preparation: Fixation of the lung
Ten each resected lung including tumor parts were divided into two specimens, one for pathological diagnoses within the standard clinical workflow, and the other for taking images by µCT for the present study. The lung specimens were maintained and fixed to obtain high-resolution images by µCT. Each specimen was inflated with a pressure of 30 cm H2O.
Micro-computed tomography
After fixation of the lung, images of the specimens were taken by µCT (made by Shimadzu Co., inspeXio SMX-90CT Plus MICRO FOCUS X-RAY CT SYSTEM). The imaging conditions were tube voltage 90 kV and tube current 110 µA, imaged at a spatial resolution of 13 µm×13 µm×13 µm/voxel using Micro-CT scanners. As for pixel number was 1024×1024× (478 to 2150).
It took almost 20 minutes to take images for one specimen.
Definition of alveolar wall thickness
After conversion to DICOM form of µCT image data, image reconstruction was obtained by the PLUTO software 7 (Fig. 1A ). Alveoli wall thickness was defined as the width of a white line on a µCT image ( Fig. 1B ). We measured alveolar wall thickness at 10 points in both the thin and thick areas on µCT for each specimen, and the average value of 10 points was defined as each thickness of the alveolar wall. To confirm whether or not those areas with thickened alveolar wall were consistent with pathologically lepidic growth pattern, we aligned two images gained by µCT and microscope using an especially developed registration method. [8] [9] [10] 
Statistical analysis
Wilcoxon test was conducted in order to compare thickness of the normal alveolar wall and thickened alveolar wall on µCT images. All analysis was conducted using the JMP software program (version 13.0.0; SAS institute Inc., Cary, NC, USA). The results are expressed as the mean ± standard deviation and a P-value of less than 0.05 was considered statistically significant.
RESULTS
All the tumors were diagnosed as adenocarcinoma. The histological subtypes 11 were as follows: adenocarcinoma in situ (n=1), minimally invasive adenocarcinomas (n=2), invasive adenocarcinomas with lepidic-predominant (n=3) and invasive adenocarcinomas with papillary predominant (n=4). The median whole tumor size was 18 mm (9 mm-24 mm) with the median invasive tumor size was 10 mm (0 mm-19 mm). The area of GGO on HRCT could be seen clearly in the µCT image as a thickened alveolar wall area ( Fig. 2-3) .
The image could be clearly divided into thin and thickened alveolar wall areas. Median thickness of normal walls was 0.037 mm (0.034 mm-0.048 mm), and that of thickened walls was 0.084 mm (0.074 mm-0.094 mm). A significant difference was observed statistically in the thickness between thin and thickened alveolar walls (P < 0.01) ( Fig. 4) . Thickened alveolar wall areas on µCT corresponded well with the lepidic growth pattern microscopically (Fig. 5 ). Fig. 2D : It could be well distinguished visually between normal alveolar walls and thickened alveolar walls. We measured the alveolar wall thickness (distance between blue lines) on µCT. Fig. 3B.  Fig. 3D : Normal alveolar walls and thickened alveolar walls could be well distinguished visually. We measured the alveolar wall thickness (distance between blue lines) on µCT.
DISCUSSION
Clinical HRCT images were used for the diagnoses of the living body (in-vivo imaging). Any computational and diagnostic imaging analysis was constrained to the millimetre scale because of the limited resolution of the HRCT imaging technology. With this scale, although pulmonary vessels and lung segment could be observed, finer detailed anatomy was not observable compared to microscopic images. µCT, on the other hand, allows imaging of ex-vivo tissues at a resolution of tens of micrometres. Using this micrometer scale, the alveoli and small airways could be clearly observed. [3] [4] [5] [6] µCT was developed for industrial use as a non-destructive inspection tool and provides extremely high-resolution images of samples. The appearance of reconstructed µCT images obtained in this study is comparable with that of microscopic images. We have attempted to take high-resolution images of the human lung using µCT. 10 Several researchers reported their study taking pulmonary specimens by µCT. Mai et al investigated the process of lung fibrosis in patients with idiopathic pulmonary fibrosis (IPF) using explant lungs prior to transplants by µCT. Their findings supported the theory that alveolar collapse might be the initial trigger for the fibroproliferative process in patients with IPF. They found that µCT could act as the bridge between thin-section CT and histological analysis. 3 McDonough et al tried to determine whether there was a relationship between small-airway obstruction and emphysematous destruction in COPD. 4 In their study, µCT was used to measure the extent of emphysema and the number of terminal bronchioles per millilitre of lung volume. They found that narrowing and disappearance of small conducting airways before the onset of emphysematous destruction could be explained by the increased peripheral airway resistance reported in COPD. In the same way, µCT has been used to reveal the etiology of pulmonary diseases. Our previous work also showed that µCT could act as a bridge between HRCT and microscopic findings. 12 On µCT images, the differences in the alveolar wall thickness between normal lung and lung cancer could be clearly observed. These differences corresponded well to the pathological findings: those areas with thin alveolar walls corresponded to the pathological area of normal lung. On the other hand, areas with thickened alveolar walls corresponded to pathological areas of lung adenocarcinoma with lepidic growth pattern. Our current results further support the notion that µCT could serve to bridge between HRCT and microscopic images.
We found that µCT images could be correctly divided as alveolar walls into normal lung areas and lung cancer areas on radiological images. Our study and other reports have pointed to micro-scale imaging as a new frontier in radiology. Further investigations are needed to make histological diagnoses using µCT images more accurate. Rapid three-dimensional imaging with µCT could well provide an advantage over conventional microscopic diagnoses which involves preparation of costly histopathological slides and much processing time. If comparable histopathological diagnoses of pulmonary nodules could be obtained by µCT within the living body, the need for lung cancer patients to be examined for pretreatment bronchoscopic or surgical lung biopsy could well be reduced in the future.
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